Megagliptin MF Tablet PR

By Megagliptin MF

Rx

10 Tablet PR in a Strip

Composition icon

Composition

Metformin(500mg) + Teneligliptin(20mg)

Manufacturer - Aristo Pharmaceuticals Pvt Ltd icon

Manufacturer - Aristo Pharmaceuticals Pvt Ltd

Mercantile Chamber, 3rd Floor, 12, J.N. Heredia Marg, Ballard Estate, Mumbai – 400 001, India.

Expires on or after icon

Expires on or after

May, 2026

About Megagliptin MF Tablet PR

Megagliptin MF Tablet PR is a medication used to control high blood sugar levels in individuals diagnosed with type 2 diabetes mellitus. It is beneficial in preventing serious complications of diabetes such as kidney damage, blindness, heart attack, or stroke. This medication can be prescribed either alone or in combination with other diabetes medicines. Incorporating a healthy diet and regular exercise routine enhances the effectiveness of this medication.

It is recommended to take Megagliptin MF Tablet PR consistently at the same time each day to maximize its benefits. Adhering to the prescribed dosage is essential for maintaining stable blood sugar levels and preventing future complications. It is crucial to follow the lifestyle recommendations provided by your healthcare provider while using this medication, as lifestyle choices significantly influence diabetes management.

Common side effects associated with Megagliptin MF Tablet PR include diarrhea, nausea, vomiting, upset stomach, and headaches. Low blood sugar levels (hypoglycemia) can occur, especially if combined with other diabetes medications such as insulin or sulfonylurea. Being aware of the symptoms of hypoglycemia and knowing how to manage it is important.

Before taking Megagliptin MF Tablet PR, inform your doctor about any history of kidney, liver, or heart disease, pancreas issues, alcohol consumption habits, as well as if you are pregnant or breastfeeding. Certain medications may interact with Megagliptin MF Tablet PR, so it is essential to disclose all medications you are currently taking to ensure safety. Regular monitoring of kidney function and blood sugar levels is necessary during the course of treatment.

Megagliptin MF Tablet PR contains a combination of two medicines, Metformin and Teneligliptin, which belong to the category of antidiabetic agents. Metformin works by reducing liver glucose production and intestinal glucose uptake, while Teneligliptin inhibits the action of the dipeptidyl Peptidase 4 enzyme, leading to increased insulin levels and reduced glucagon levels in the body, ultimately lowering sugar levels.

Patients using Megagliptin MF Tablet PR may experience side effects such as nausea, vomiting, diarrhea, headaches, stomach ache, and other associated symptoms. It is crucial not to take this medication if allergic to any of its components or if diagnosed with conditions like heart failure, bladder cancer, or diabetic ketoacidosis. Instances of lactic acidosis, characterized by the accumulation of lactic acid in the blood, may occur and require immediate medical attention, especially in individuals with kidney or liver diseases. Avoiding alcohol consumption or prolonged fasting is advised, and consultation with a healthcare provider is necessary for individuals who are pregnant, planning for pregnancy, or breastfeeding.


Benefits

Megagliptin MF Tablet PR offers several benefits for individuals with Type 2 diabetes mellitus. This medication combines two powerful medicines that work together to effectively lower blood glucose levels. Managing blood glucose levels is crucial in diabetes care as it can help reduce the risk of serious complications associated with the condition, such as kidney damage, eye damage, nerve problems, and even the loss of limbs. By maintaining proper control over blood glucose levels with the help of Megagliptin MF Tablet PR, individuals can also lower their risk of developing heart disease and stroke.


Consistent use of this medication, in conjunction with a healthy diet and regular exercise, can significantly improve the quality of life for individuals with Type 2 diabetes mellitus. By following the prescribed regimen, patients can lead a normal and healthy life while effectively protecting their future health. It is essential to adhere to the treatment plan outlined by healthcare providers to ensure maximum benefits and long-term health outcomes. Megagliptin MF Tablet PR is a valuable tool in the management of diabetes, offering individuals a chance to take control of their health and well-being.


How to use the Megagliptin MF Tablet PR

To properly use Megagliptin MF Tablet PR, it is important to follow the advice of your doctor or carefully read the instructions on the label before using it. This medication should be taken with food. Make sure to adhere to the prescribed dosage and do not exceed it without consulting your healthcare provider. Taking Megagliptin MF Tablet PR as directed can help you experience the full benefits of the medication while minimizing the risk of side effects. If you have any questions or concerns about how to use this medication, do not hesitate to reach out to your doctor for further guidance.


Uses of Megagliptin MF Tablet PR

Megagliptin MF Tablet PR is primarily used for the treatment of Type 2 diabetes mellitus. This medication helps in controlling blood sugar levels in individuals with this condition. By effectively managing glucose levels, Megagliptin MF Tablet PR can assist in reducing the risk of complications associated with diabetes. It is important to follow the prescribed dosage and advice of a healthcare professional when using Megagliptin MF Tablet PR to achieve optimal results in managing Type 2 diabetes mellitus.


What conditions Megagliptin MF Tablet PR treats?

Megagliptin MF Tablet PR is used to treat type 2 diabetes mellitus by controlling high blood sugar levels. This helps prevent complications of diabetes like kidney damage and blindness. Taking the medicine with a healthy diet and exercise routine is important. Common side effects may include upset stomach and headache. Individuals with certain medical conditions should consult their doctor before taking this medicine. Pregnant or breastfeeding women should also seek medical advice. It's crucial to follow your doctor's recommendations, as this medicine aims to control blood sugar levels and reduce the risk of serious complications associated with diabetes.


Should you consult a doctor?

If you experience any persistent side effects such as nausea, vomiting, headache, diarrhea, or low blood sugar level (hypoglycemia), you should seek medical attention promptly. Additionally, if you have a history of kidney, liver, or heart disease, pancreas issues, or if you consume alcohol excessively, consult your doctor before taking Megagliptin MF Tablet PR. Pregnant or breastfeeding women should also seek medical advice before initiating this medication. It is crucial to inform your doctor about all medications you are currently taking to prevent any potential interactions. Regular monitoring of kidney function and blood sugar levels is essential during treatment. If you have concerns about the medication or if side effects persist, do not hesitate to consult your healthcare provider. Remember, your doctor is there to help you manage your condition effectively and safely.


Side effects of Megagliptin MF Tablet PR

When taking Megagliptin MF Tablet PR, some possible side effects may occur. These side effects are usually mild and temporary, often improving as your body gets used to the medication. Common side effects include nausea, vomiting, headache, hypoglycemia (low blood glucose level), and diarrhea. If these side effects persist or cause concern, it is important to consult your doctor for further evaluation and guidance.


Safety advice

scroll

liver

Megagliptin MF Tablet PR should be avoided by patients with liver disease as it may not be safe for them. It is important to consult your doctor before using this medication to ensure your liver health is not at risk.

scroll

kidney

Megagliptin MF Tablet PR requires caution in patients with kidney disease. Dose adjustment and monitoring may be necessary. It is not recommended for severe kidney disease. Regular kidney function tests are advisable during the treatment.

scroll

alcohol

It is unsafe to drink alcohol while taking Megagliptin MF Tablet PR.

scroll

driving

When taking Megagliptin MF Tablet PR, avoid driving if you have symptoms affecting concentration and reaction time. It is unsure if this medication impacts driving ability.

scroll

pregnancy

Megagliptin MF Tablet PR may be harmful during pregnancy, based on animal studies. Consult your doctor, who will consider the risks and benefits before prescribing it.

scroll

breastfeeding

Megagliptin MF Tablet PR is considered unsafe for breastfeeding. Limited data shows potential harm to the baby as the drug may pass into breastmilk.


Consumption warning before consuming Megagliptin MF Tablet PR

Before consuming Megagliptin MF Tablet PR, it is essential to note that this medication helps control high blood sugar levels in individuals with type 2 diabetes. It aids in preventing severe diabetes-related complications and may lower the risk of heart attack or stroke. Megagliptin MF Tablet PR is usually prescribed alone or in combination with other diabetes medications for optimal efficacy when paired with a balanced diet and regular exercise routine.


Take this medication consistently at the same time daily unless advised otherwise by your healthcare provider. Its effectiveness is crucial for maintaining stable blood sugar levels and reducing future complications. Adhering to the prescribed diet and exercise regimen is fundamental in managing diabetes effectively.


Common side effects may include stomach discomfort, headache, diarrhea, nausea, and vomiting. Hypoglycemia (low blood sugar levels) may occur, especially when combined with insulin or sulfonylurea medications. It's imperative to recognize and manage hypoglycemia promptly.


Inform your doctor about any history of kidney, liver, or heart disease, pancreatic issues, or alcohol consumption. Pregnant or breastfeeding individuals should consult their healthcare provider before starting the medication. Be cautious of potential interactions with other medications, and avoid excessive alcohol consumption as it can impact blood glucose levels. Regular monitoring of kidney function and blood sugar levels is necessary during treatment.


What if you forgot to take Megagliptin MF Tablet PR?

If you forget to take a Megagliptin MF Tablet PR dose, try to take it as soon as you remember. However, if it is close to the time for your next scheduled dose, it is better to skip the missed one and stick to your usual dosing routine. Avoid taking a double dose to make up for the missed one, as this can increase the risk of side effects.


Related lab tests

When taking Megagliptin MF Tablet PR, it is important to monitor your glucose levels regularly through specific lab tests. These tests help to keep track of how well the medication is working for you. The first test is the Glucose - Fasting Blood test, which measures the amount of sugar in your blood after fasting for a certain period of time. The second test is the Glucose - Postprandial Blood test, which checks your blood sugar levels after eating. Lastly, the Glycosylated Hemoglobin test, also known as HbA1c, shows your average blood sugar level over the past 2-3 months. These tests are essential in managing diabetes and ensuring the effectiveness of Megagliptin MF Tablet PR.


Related Lab Tests:

1. Glucose - Fasting Blood

2. Glucose - Postprandial Blood

3. Glycosylated Hemoglobin (HbA1c)


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassANTI DIABETIC
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

175

Inclusive of all taxes

Content verified by

chevron-right

Dr. Gowri Kulkarni

MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)

Last update on 01-Oct-2024